Clinical Trial Update: Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function [Phase 3]

View source ↗

Summary

Phase 3 clinical trial sponsored by AstraZeneca to evaluate the Balcinrenone and dapagliflozin combination in patients with heart failure and impaired kidney fu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Balcinrenone
• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure and Impaired Kidney Function | Phase 3 | Status: RECRUITING